Abstract
Hepatocyte growth factor/scatter factor (HGF/SF) stimulates the invasive growth of epithelial cells via the c-MET oncogene-encoded receptor. In normal lung, both the receptor and the ligand are detected, and the latter is known to be a mitogenic and a motogenic factor for both cultured bronchial epithelial cells and non-small-cell carcinoma lines. Here, ligand and receptor expression was examined in 42 samples of primary human non-small-cell lung carcinoma of different histotype. Each carcinoma sample was compared with adjacent normal lung tissue. The Met/HGF receptor was found to be 2 to 10-fold increased in 25% of carcinoma samples (P = 0.0113). The ligand, HGF/SF, was found to be 10 to 100-fold overexpressed in carcinoma samples (P < 0.0001). Notably, while HGF/SF was occasionally detectable and found exclusively as a single-chain inactive precursor in normal tissues, it was constantly in the biologically-active heterodimeric form in carcinomas. Immunohistochemical staining showed homogeneous expression of both the receptor and the ligand in carcinoma samples, whereas staining was barely detectable in their normal counterparts. These data show that HGF/SF is overexpressed and consistently activated in non-small-cell lung carcinomas and may contribute to the invasive growth of lung cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olivero, M., Rizzo, M., Madeddu, R. et al. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer 74, 1862–1868 (1996). https://doi.org/10.1038/bjc.1996.646
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.646
This article is cited by
-
MiR-144-3p inhibits the proliferation and metastasis of lung cancer A549 cells via targeting HGF
Journal of Cardiothoracic Surgery (2022)
-
Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer
Cellular Oncology (2021)
-
The multiple paths towards MET receptor addiction in cancer
Oncogene (2018)
-
Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells
Clinical & Experimental Metastasis (2013)
-
New Targets in Non-Small Cell Lung Cancer
Current Oncology Reports (2013)